Lipid- and polymer-based nanoparticle systems for the delivery of CRISPR/Cas9

被引：33

作者：

Ashok, Bhaargavi ^{[1
]}

Peppas, Nicholas A. ^{[1
,2
,3
,4
,5
]}

Wechsler, Marissa E. ^{[6
]}

机构：

[1] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA

[2] Univ Texas Austin, Inst Biomat Drug Delivery & Regenerat Med, Austin, TX 78712 USA

[3] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA

[4] Univ Texas Austin, Coll Pharm, Div Mol Pharmaceut & Drug Delivery, Austin, TX 78712 USA

[5] Univ Texas Austin, Dell Med Sch, Dept Surg & Perioperat Care, Austin, TX 78712 USA

[6] Univ Texas San Antonio, Dept Biomed Engn & Chem Engn, San Antonio, TX 78249 USA

来源：

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY | 2021年 / 65卷

基金：

美国国家卫生研究院;

关键词：

Hydrogels; Nanoparticles; CRISPR; Genome editing; IN-VIVO; TARGETED DELIVERY; MESSENGER-RNA; T-CELLS; GENE; CARRIERS; CANCER; VITRO; DNA; CRISPR-CAS9;

D O I：

10.1016/j.jddst.2021.102728

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The discovery of clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) genome editing systems and their applications in human health and medicine has heralded a new era of biotechnology. However, the delivery of CRISPR therapeutics is arguably the most difficult barrier to overcome for translation to in vivo clinical administration. Appropriate delivery methods are required to efficiently and selectively transport all gene editing components to specific target cells and tissues of interest, while minimizing off-target effects. To overcome this challenge, we discuss and critique nanoparticle delivery strategies, focusing on the use of lipid-based and polymeric-based matrices herein.

引用

页数：13

共 50 条

[41] Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment q
Xu, Xiaoyu
Liu, Chang
Wang, Yonghui
Koivisto, Oliver
Zhou, Junnian
Shu, Yilai
Zhang, Hongbo
ADVANCED DRUG DELIVERY REVIEWS, 2021, 176
[42] Cell Reprogramming With CRISPR/Cas9 Based Transcriptional Regulation Systems
Shakirova, Ksenia M.
Ovchinnikova, Viktoriia Y.
Dashinimaev, Erdem B.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2020, 8
[43] Finely tuned ionizable lipid nanoparticles for CRISPR/Cas9 ribonucleoprotein delivery and gene editing
Im, San Hae
Jang, Mincheol
Park, Ji-Ho
Chung, Hyun Jung
JOURNAL OF NANOBIOTECHNOLOGY, 2024, 22 (01)
[44] Harnessing nanoparticles for the efficient delivery of the CRISPR/Cas9 system
Rahimi, Hossein
Salehiabar, Marziyeh
Charmi, Jalil
Barsbay, Murat
Ghaffarlou, Mohammadreza
Razligh, Mahdi Roohi
Davaran, Soodabeh
Khalilov, Rovshan
Sugiyama, Minetaka
Nosrati, Hamed
Kaboli, Saeed
Danafar, Hossein
Webster, Thomas J.
NANO TODAY, 2020, 34
[45] Delivery methods for CRISPR/Cas9 gene editing in crustaceans
Xu, Sen
Pham, Thinh
Neupane, Swatantra
MARINE LIFE SCIENCE & TECHNOLOGY, 2020, 2 (01) : 1 - 5
[46] Applications and Research Advances in the Delivery of CRISPR/Cas9 Systems for the Treatment of Inherited Diseases
Lu, Xinyue
Zhang, Miaomiao
Li, Ge
Zhang, Shixin
Zhang, Jingbo
Fu, Xiaoge
Sun, Fengying
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (17)
[47] CRISPR RNA-guided autonomous delivery of Cas9
Wilkinson, Royce A.
Martin, Coleman
Nemudryi, Artem A.
Wiedenheft, Blake
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2019, 26 (01) : 14 - 24
[48] TARGETED DELIVERY OF CRISPR/CAS9 INTO THE ADULT MOSQUITO GERMLINE
Chaverra-Rodriguez, Duverney
Macias, Vanessa M.
Hughes, Grant L.
Suzuki, Yasutsugu
Peterson, David R.
Pujhari, Sujit
Rasgon, Jason L.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 459 - 459
[49] Delivery methods for CRISPR/Cas9 gene editing in crustaceans
Sen Xu
Thinh Phu Pham
Swatantra Neupane
Marine Life Science & Technology, 2020, 2 : 1 - 5
[50] CRISPR/Cas9 Inducible Systems for Neurodegenerative Disease
Asmus, Natalie
Kantor, Boris
MOLECULAR THERAPY, 2021, 29 (04) : 415 - 415

← 1 2 3 4 5 →